견적문의

TAIPEI--( / )--GIGABYTE, a global leader in technology, joins MWC 2022 as the world’s most influential connectivity event takes spotlight from February 28th to March 3rd. The event creates opportunities for business leaders and trailblazers to network and share their thought leadership about the critical transformations shaping the industry and global economy in a 5G standardized era.

GIGABYTE expects to use its strength of rich product diversity and engineering expertise, to demonstrate the scope of impact data center and embedded products have beyond improving the connectivity of telecommunications, which opens up endless opportunities in a smart city.

GIGABYTE is an early adopter to design servers for Arm® architecture, the world’s most recognizable architecture for telecommunications, and is pleased to have two Arm server systems demo live at Arm’s booth at MWC including a network-in-a-box 5G solution and a solution compromised of an enterprise private network and a GPU. These demos are powered by the Ampere® Altra® cloud-native processors with massive core counts, and are available to the Arm ecosystem through the Arm 5G Solutions Lab, which is a place for hardware and software ecosystem partners can come together and demonstrate end-to-end solutions in a live test environment. The Arm-based 5G edge servers will exemplify future connectivity that has greater speeds, lower latency, and is able to connect more devices.

As a partner of global automobile manufacturers, GIGABYTE specializes in developing decision-making control units for different types of autonomous vehicles, as well as customized products such as ADAS ECUs, TCUs, assisting vehicle designers to develop their ideal products. The AI-enabled decision making control units will activate a traffic grid that’s smarter hence smoother and safer.

GIGABYTE brought its latest generation of embedded systems and developed Automated Guided Vehicle (AGV), which can be programmed to maneuver in designated routes, and Autonomous Mobile Robot (AMR), which can detect and avoid obstacles through navigation to operate. The systems are designed to provide critical features such as low power consumption, high performance with rich I/O interface and high expansion flexibility, offering a go-to choice to facilitate an automated environment for vital industries.

GIGABYTE’s recent project is a two-phase immersion cooling data center built for the prominent IC foundry giant that leads the world in advanced process technology. The project is aimed to not only prepare technology companies to combat the thermal dilemma associated with the ever-increasing CPU/GPU performance by providing a future-proof cooling solution, but also to set the industry standard for modern data centers to effectively deliver better TCO, smaller carbon footprint, and yield high(er) computing performance.

GIGABYTE continues its strong presence in digital format on both MWC’s exhibitors’ page, which provides access to products info and downloadable PDFs, and its own [INUDSTRY] page, which offers an interactive 3D overview of different industries envisioned in modern perspective with GIGABYTE’s comprehensive products and solutions.

GIGABYTE @ MWC 2022 -

INDUSTRY:

Photos/Multimedia Gallery Available:GIGABYTE Reimagines Connectivity With Servers and Embedded Systems as MWC Returns to Barcelona

WESTON, MASS.--( / )--Aquyre Biosciences, Inc. today announced the appointment of F. Samuel Eberts 읍중동홀덤카페 전저수 III as Chief Executive Officer and Chairman of its Board of Directors. Founder Bertrand de Poly will assume the role of 송천동맞고 화장품블로그 Chief 조이맥심 WESTON,& Technology 읍중동홀덤카페 눈썹털 Officer, focusing on strategy and technological development, along with his continued service on the board.

This evolution in management aims to take the company to its next stage of growth, 읍중동홀덤카페 메이크샵 building on recent achievements including the acceptance of a clinical study manuscript with Johnson & Johnson at Boston University 송천동맞고 아이라인추천 and Fox Chase Cancer Center, to be presented at the American Thoracic Society meeting in Washington, DC on May 19-24, 2023.

Samuel Eberts brings to Aquyre Biosciences decades of experience at the intersection of healthcare, law, and academia. His varied career includes equity partnership and board, and investment committee membership at a private equity firm whose collaboration with Harvard-affiliated Mass General’s Wellman Center facilitated world-class medical insights, and ongoing engagements as a Partner at Market Street HealthCare Partners, a private equity sponsor for healthcare investments. For 15 years, Sam was part of the senior management team at LabCorp, where he served as Chief Legal Officer, Corporate Secretary, and Senior Vice President of Corporate Affairs, with oversight of regulatory, government relations, and merger and acquisition activities. He is a senior advisor for healthcare investments to Aquyre’s shareholder, Invescore. Sam is also a Senior 송천동맞고 바카라추천 Lecturing Fellow at Duke University School of Law, a member of the advisory board for the Wilson Center, and has served on the World Policy Institute Advisory Board, the Harvard Law School Corporate Governance Forum, and the John F. Kennedy School of Government Healthcare Policy Leadership Council. He also serves on the board 읍중동홀덤카페 우리바카라 of several non-profit organizations. 읍중동홀덤카페 다모아카지노

“I am delighted that Samuel has agreed to help take Aquyre to the next 송천동맞고 윤아다리스타킹 level of its growth journey as we further refine our technology MLBPARK “Iscale our partner solutions and corporate operations. I look forward to working with him to help ensure 읍중동홀덤카페 윤아오다리 the success of our company,” said Bertrand de Poly.

“I am particularly pleased that among the many shareholders of Aquyre, Canon Medical Systems Corporation, the medical equipment subsidiary of the optical, imaging, and industrial multinational Canon, Inc., is a strategic investor,” said Samuel Eberts. “I am honored to be leading such an impressive 읍중동홀덤카페 collection of people and products and am excited about 읍중동홀덤카페 온라인바카라주소 the potential of Aquyre Biosciences. It is humbling and exciting to 읍중동홀덤카페 mgm be part of an organization that will play an important role in healthcare. We are well positioned to bring a new level of precision in diagnosis of cancer, improving the lives of patients.”

About 읍중동홀덤카페 Aquyre Biosciences 읍중동홀덤카페 섯다

Aquyre Biosciences, Inc is the creator of CelTivity™, the industry leader in two-minute 읍중동홀덤카페 바카라사이트 lung 읍중동홀덤카페 bacara biopsy adequacy assessment. Powered by two proprietary technologies 송천동맞고 사다리게임 including Dynamic Cell Imaging™ (DCI), CelTivity can scan a biopsy and measure intracellular and metabolic activity throughout extracted tissue. This activity is presented in a heatmap, making it easy to interpret. The assessment does not require any cutting or staining, meaning the same tissue assessed for adequacy can go to final pathology to review for cancer, granuloma, lymphocytes, and more. Aquyre 읍중동홀덤카페 Biosciences is headquartered out of Weston, Mass. For more information, please visit

View source version on 읍중동홀덤카페 장현승기습키스 businesswire.com:Aquyre Biosciences Announces Appointment of F. Samuel 읍중동홀덤카페 인기가요노출 Eberts III as CEO and AV디비에스 Viewof the Board of Directors & Founder Bertrand de Poly as Chief Strategy & 읍중동홀덤카페 버블팝뮤비 Technology Officer